BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 19729669)

  • 1. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.
    Flume PA; Mogayzel PJ; Robinson KA; Goss CH; Rosenblatt RL; Kuhn RJ; Marshall BC;
    Am J Respir Crit Care Med; 2009 Nov; 180(9):802-8. PubMed ID: 19729669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.
    Flume PA; O'Sullivan BP; Robinson KA; Goss CH; Mogayzel PJ; Willey-Courand DB; Bujan J; Finder J; Lester M; Quittell L; Rosenblatt R; Vender RL; Hazle L; Sabadosa K; Marshall B;
    Am J Respir Crit Care Med; 2007 Nov; 176(10):957-69. PubMed ID: 17761616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax.
    Flume PA; Mogayzel PJ; Robinson KA; Rosenblatt RL; Quittell L; Marshall BC; ;
    Am J Respir Crit Care Med; 2010 Aug; 182(3):298-306. PubMed ID: 20675678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary exacerbations in cystic fibrosis.
    Stenbit AE; Flume PA
    Curr Opin Pulm Med; 2011 Nov; 17(6):442-7. PubMed ID: 21881509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of β-lactams as single agents for treating severe pulmonary exacerbations during pregnancy in cystic fibrosis.
    Prickett M; Jain M
    Am J Respir Crit Care Med; 2012 Dec; 186(12):1310-1. PubMed ID: 23250504
    [No Abstract]   [Full Text] [Related]  

  • 6. Cystic fibrosis pulmonary guidelines: airway clearance therapies.
    Flume PA; Robinson KA; O'Sullivan BP; Finder JD; Vender RL; Willey-Courand DB; White TB; Marshall BC;
    Respir Care; 2009 Apr; 54(4):522-37. PubMed ID: 19327189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical approach to lung disease in patients with cystic fibrosis.
    O'Sullivan BP; Flume P
    Semin Respir Crit Care Med; 2009 Oct; 30(5):505-13. PubMed ID: 19760538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of the utilization of anti-pseudomonal beta-lactam therapy in cystic fibrosis patients.
    Zobell JT; Young DC; Waters CD; Ampofo K; Cash J; Marshall BC; Olson J; Chatfield BA
    Pediatr Pulmonol; 2011 Oct; 46(10):987-90. PubMed ID: 21520438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing outcomes of pulmonary exacerbations in cystic fibrosis.
    Szentpetery S; Flume PA
    Curr Opin Pulm Med; 2018 Nov; 24(6):606-611. PubMed ID: 30124523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pulmonary exacerbations in adult cystic fibrosis patients: a review.
    Barto TL; Flume PA
    Hosp Pract (1995); 2010 Feb; 38(1):26-34. PubMed ID: 20469621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modern methods in the treatment of cystic fibrosis].
    Bush A
    Pediatr Pol; 1996 Jun; 71(6):566-72. PubMed ID: 8756778
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel approach to the eradication of Pseudomonas aeruginosa in an infant with CF after outpatient treatment failure.
    Hayes D; Kanga JF; Anstead MI; Kuhn RJ
    Pediatr Pulmonol; 2008 May; 43(5):511-3. PubMed ID: 18383117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of the patient with mucoviscidosis].
    ;
    Rev Mal Respir; 2003 Feb; 20(1 Pt 1):149-57. PubMed ID: 12739564
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibiotic therapy for pulmonary exacerbations in adults with cystic fibrosis.
    Elpern EH; Patel G; Balk RA
    Medsurg Nurs; 2007 Oct; 16(5):293-8; quiz 299. PubMed ID: 18072667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis.
    Esmond G; Butler M; McCormack AM
    J Clin Nurs; 2006 Jan; 15(1):52-60. PubMed ID: 16390524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin versus tobramycin plus azlocillin in pulmonary exacerbations in adult patients with cystic fibrosis.
    Bosso JA; Black PG; Matsen JM
    Am J Med; 1987 Apr; 82(4A):180-4. PubMed ID: 3555033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Inpatient Cystic Fibrosis Pulmonary Exacerbations.
    Cogen JD; Oron AP; Gibson RL; Hoffman LR; Kronman MP; Ong T; Rosenfeld M
    Pediatrics; 2017 Feb; 139(2):. PubMed ID: 28126911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study].
    da Silva Santos CI; Gonçalves de Oliveira Ribeiro MA; Moreno Morcillo A; Fernando Ribeiro A; Dirceu Ribeiro J
    Arch Bronconeumol; 2010 Jun; 46(6):310-6. PubMed ID: 20417019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhaled therapies for cystic fibrosis].
    Lahzami S; Nicod LP
    Rev Med Suisse; 2011 Nov; 7(318):2285-8. PubMed ID: 22400363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment of cystic fibrosis].
    Fleer A; Roord JJ; van der Laag J
    Ned Tijdschr Geneeskd; 1986 Oct; 130(42):1910-1. PubMed ID: 3785462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 38.